US-based medical device company, ICON Interventional Systems, has gained the CE mark for the Nuloy coronary stent system, used to treat patients with cardiovascular disorders.
The Nuloy coronary stent is made from a molybdenum and rhenium (MoRe) alloy, which is 99.9% pure and nickel-free with superior strength and density, compared to standard stent materials such as cobalt chromium and stainless steel.
The MoRe alloy provides strength and recoil resistance with better radiographic visibility, allowing the stent to be formed with a wall thickness of approximately one-half that of conventional products. The Nuloy coronary system provides improved deliverability to tight, tortuous and distal lesions, the company said.
Piedmont Heart Institute, Atlanta, US, professor David Kandzari said the stent system will offer the potential of a new standard in deliverability, due to the extremely thin struts, flexibility and low profile.
"Importantly, the stent has radiographic visibility and radial strength equivalent to much bulkier devices," Kandzari added.
Colombus Hospital Milan, Italy, Dr. Antonio said: "I have reviewed this new device and look forward to using it clinically, as it may offer a very strong advantage in enhanced visibility. In addition, the thin struts and excellent deliverability should lead to very favourable BMS clinical results."
Icon has received three issued patents related to the stent platform and continues to pursue IP protection in major markets around the world. The company is developing distribution and manufacturing options for commercial sale of the Nuloy stent system in the Europe. Icon Interventional Systems develops next generation cardiovascular solutions for patients and doctors worldwide.
Image: A stent is an artificial ‘tube’ inserted into a natural passage / conduit in the body to prevent, or counteract, a disease-induced, localized flow constriction.
